tirzepatide sore neck Severe reaction to injection Tirzepatide Injections for Medical Weight

There were significant LS-mean between-group differences in fasting glucose (-0.95 mmol/L), 2-hour glucose post-OGTT (-2.4 mmol/L) in the high GLP-1 T2D group

But is there more to this side effect than meets the eye

Hepatic Impairment A lower or less frequent dosage should be used in patients with hepatic impairment [see Clinical Pharmacology (12.3) and Use in Specific Populations (8.6)]

prepaid math

Some patients explore tirzepatide alternatives or alternative GLP-1 options for long-term maintenance, including phentermine or other weight management medications that may be less expensive for maintenance purposes